ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 113 filers reported holding ORIC PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2 | -33.3% | 249 | 0.0% | 0.00% | – |
| Q1 2024 | $3 | – | 249 | +84.4% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 135 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 135 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | -50.0% | 135 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | -33.3% | 135 | 0.0% | 0.00% | – |
| Q3 2021 | $3,000 | +200.0% | 135 | +95.7% | 0.00% | – |
| Q2 2021 | $1,000 | -50.0% | 69 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 69 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | – | 69 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 496,893 | $16,760,000 | 14.90% |
| Svennilson Peter | 4,768,181 | $160,831,000 | 13.45% |
| Invus Financial Advisors, LLC | 1,007,576 | $33,986,000 | 12.28% |
| EcoR1 Capital, LLC | 2,642,218 | $89,122,000 | 6.58% |
| Foresite Capital Management IV, LLC | 125,000 | $4,216,000 | 2.05% |
| Orbimed Advisors | 2,921,967 | $98,558,000 | 1.39% |
| Casdin Capital, LLC | 251,515 | $8,484,000 | 0.50% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 191,568 | $6,462,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 300,000 | $10,119,000 | 0.30% |
| EMERALD ADVISERS, LLC | 186,140 | $6,279,000 | 0.27% |